Health: Hope Sprouts Eternal
A guide to what's available now to cure baldness—and what's on the horizon
By Karen Springen
Feb. 9 issue - Ken Washenik, 44, uses every available weapon in his battle against baldness. More than 15 years
ago he started rubbing Rogaine onto his scalp twice a day. Five years ago he added the pill Propecia to his daily
regimen. And over the last two years he's relocated 2,200 follicles from the back of his head to the sparser region
on top. His next step? Washenik, a New York University dermatologist who recently took over as medical director
of the hair-transplant company Bosley, is tackling the holy grail of hair loss: trying to figure out how to clone the
cells responsible for hair growth.
OK, so curing baldness won't save lives. But it will undoubtedly ease the emotional suffering of millions. Each year, those 80 million follicularly challenged men and women pour $2 billion into the quest for the magic pill, medical procedure—or at least the perfect wig, says Chris Webb, editor of The National Hair Journal. Tip Sheet offers a guide to what's available now—and what's on the horizon:
Buyer beware: so far, the FDA has approved only two antibaldness medications: minoxidil, sold
over the counter as Rogaine, for both men and women, and finasteride, a prescription pill sold as Propecia, for
men only. Both drugs are pricey: a year's supply of Rogaine costs about $200, Propecia about $720—and, like
other baldness treatments, they're not covered by insurance. For best results, many men have combined both
drugs. Check the North American Hair Research Society's Web site (nahrs.org
) for more information.
The good news is that surgery no longer means obvious plugs: clumps of 15 to 20 hairs
replanted like a cabbage patch. Today doctors can move hairs like blades of grass—one to four follicles at a time.
Each year 100,000 Americans opt for the procedure, which typically costs about $6,000 and requires a local
anesthetic. But don't expect miracles: you'll probably still look as if you have thinning hair. "There's no way we
can create a hairline like when [you] were 12," says Robert Leonard, past president of the International Society
of Hair Restoration Surgery (ishrs.org
For patients with truly shiny pates, there may not be enough hair on the sides of their heads to cover
what they've lost up top. "It's basically taking from Peter to pay Paul," says Duke University dermatologist Elise
Olsen. With cloning, there would be an unlimited supply. Even the genetically blessed could thicken their tresses
with regenerated cells—a surgical alternative to hair extensions. "There would not be a theoretical limit other
than space on your scalp," says Washenik, who hopes to clone follicles within five years, though other doctors
say the technology is farther away. Hurdles include making sure the cloned hairs match the originals in color,
texture and direction of growth.
No one knows how long it will take, but someday doctors hope to be able to manipulate the
genes that cause hair loss. Unfortunately, there's more than one gene involved. "Male-pattern hair loss is what
we call a complex-trait disease," says Columbia University geneticist Angela Christiano, who has discovered three
baldness genes so far.
Americans still spend about $600 million on semipermanent hairpieces that bind to your natural
hair and need to be adjusted every three to six weeks as your own hair grows. In the meantime, men might
consider simply accepting their fate. As celebrities like Vin Diesel and Michael Jordan have shown, bald can be
arasites in ustainable P Know your Anthelmintic Gr 2012 ench and inject inject corr must be given according to manufacturers instructions. Subcutaneous products should begiven using a 1.6cm needle making sure it is underthe skin of the neck 10-15cm below the ear. Intramuscular injections go into the mid neck witha 2.5-4cm needle aiming inwards and upwards
List of substances banned for use in cosmetic products as from 1 December 2010 The following substances are classified as CMR substances of category 1A, 1B or 2 under Commission Regulation 790/2009, amending Regulation 1272/2008.1 Therefore they are banned for use in cosmetic products as from 1 December 2010 (which is the date of application of their classification), in accordance with Arti